Multiple factors contribute to the toxicity of the aromatic retinoid, TTNPB (Ro 13-7410): Binding affinities and disposition

Toxicology and Applied Pharmacology

Volumn 142, Issue 2, 1997, Pages 319-327

  Pignatello, Michael A ^a,b   Kauffman, Frederick C ^a   Levin, Arthur A ^b,c  

^a RUTGERS UNIVERSITY   (United States)

^b Hoffmann La Roche Department of Toxicology and Pathology   (United States)

^c ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1 PROPENYL]BENZOIC ACID; AROTINOID;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHONDROGENESIS; DRUG RECEPTOR BINDING; LIMB BUD; MOUSE; NONHUMAN; TERATOGENESIS;

ANIMALIA;

EID: 0031062303     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.8047     Document Type: Article

References (45)

1. Allenby, G., Bocquel, M. T., Saunders, M., Kazmer, S., Speck, J., Rosenberger, M., Lovey, A., Kastner, P., Grippo, J. F., Chambon, P., and Levin, A. A. (1993). Retinoic acid receptors and retinoid X receptors: Interactions with endogenous retinoic acids. Proc. Natl. Acad. Sci. USA 90, 30-34.
2. Allenby, G., Janocha, R., Kazmer, S., Speck, J., Grippo, J. F., and Levin, A. A. (1994). Binding of 9-cis-retinoic acid and all-trans-retinoic acid to retinoic acid receptors α, β, and γ. J. Biol. Chem. 269, 16689-16695.
3. Bollag, W. (1974). Therapeutic effects of an aromatic retinoic acid analog on chemically induced skin papillomas and carcinomas of mice. Eur. J. Cancer 10, 731-737.
4. Boylan, J. F., and Gudas, L. J. (1991). Overexpression of the cellular retinoic acid binding protein-I (CRABP-I) results in a reduction in differentiation-specific gene expression in F9 teratocarcinoma cells. J. Cell Biol. 112, 965-979.
5. Crettaz, M., Baron, A., Siegenthaler, G., and Hunziker, W. (1990). Ligand specificities of recombinant retinoic acid receptors RARα and RARβ. Biochem. J. 272, 391-397.
6. Darmon, M., Rocher, M., Cavey, M. T., Martin, B., Rabilloud, T., Delescluse, C., and Shroot, B. (1988). Biological activity of retinoids correlates with affinity for nuclear receptors but not for cytosolic binding protein. Skin Pharmacol. 1, 161-175.
7. DeLean, A., Munson, P. J., and Rodbard, D. (1978). Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay and physiological dose-response curves. Am. J. Physiol. 235(2), E97-E102.
8. Evans, R. M. (1988). The steroid and thyroid hormone receptor superfamily. Science 240, 889-895.
9. Fiorella, P. D., and Napoli, J. L. (1991). Expression of cellular retinoic acid binding protein (CRABP) in Escherichia coli. J. Biol. Chem. 266, 16572-16579.
10. Fogh, K., Voorhees, J. J., and Åström, A. (1993). Expression, purification, and binding properties of human cellular retinoic acid-binding protein type I and type II. Arch. Biochem. Biophys. 300, 751-755.
11. Frolik, C. A., Roberts, A. B., Travela, T. E., Roller, P. P., Newton, D. L., and Sporn, M. B. (1979). Isolation and identification of 4-hydroxy-and 4-oxoretinoic acid. In vitro metabolites of all-trans-retinoic acid in hamster trachea and liver. Biochemistry 18, 2092-2097.
12. Geelen, J. A. G. (1979). Hypervitaminosis A induced teratogenesis. Crit. Rev. Toxicol. 6, 351-375.
13. Giguere, V., Lyn, S., Yip, P., Siu, C-H., and Amin, S. (1990). Molecular cloning of cDNA encoding a second cellular retinoic acid-binding protein. Proc. Natl. Acad. Sci. USA 87, 6233-6237.
14. Green, S., Issemann, I., and Sheer, E. (1988). A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res. 16, 369.
15. Grippo, J. F., and Gudas, L. J. (1987). The effect of dibutyryl cyclic AMP and butyrate on F9 teratocarcinoma cellular retinoic acid-binding protein activity. J. Biol. Chem. 262, 4492-4500.
16. Heyman, R. A., Mangelsdorf, D. J., Dyck, J. A., Stein, R. B., Eichele, G., Evans, R. M., and Thaller, C. (1992). 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68, 397-406.
17. Howard, W. B., Willhite, C. C., Sharma, R. P., Omaye, S. T., and Hatori, A. (1989a). Pharmacokinetics, tissue distribution and placental permeability of tetrahydro-tetramethyl-naphthylenyl-propenyl benzoic acid (a retinoidal benzoic acid derivative) in hamsters. Eur. J. Drug Metab. Pharmacol. 14, 153-159.
18. Howard, W. B., Willhite, C. C., Omaye, S. T., and Sharma, R. P. (1989b). Comparative distribution, pharmacokinetics and placental permeabilities of all trans-retinoic acid. Arch. Toxicol. 63, 112-120.
19. Howard, W. B., Sharma, R. P., Willhite, C. C., and Dawson, M. I. (1990). Binding affinities of retinoids to fetal cellular retinoic acid-binding protein (CRABP) in relation to their teratogenic potency in hamsters. Biochem. Pharmacol. 40, 643-648.
20. Kistler, A. (1981). Structure-activity relationship of retinoids in fetal rat bone cultures. Calcif. Tissue Int. 33, 249-254.
21. Kistler, A. (1987). Limb bud cell cultures for estimating the teratogenic potential of compounds. Arch. Toxicol. 60, 403-414.
22. Kistler, A., Galli, B., and Howard, W. B. (1990). Comparative teratogenicity of three retinoids: The arotinoids Ro 13-7410, Ro 13-6298 and Ro 15-1570. Arch. Toxicol. 64, 43-48.
23. Kochhar, D. M. (1987). Mechanisms by which retinoids intercept developmental events of the mammalian limb. In Approaches to Elucidate Mechanisms of Teratogenesis (F. Welsch, Ed.), pp. 197-213. Hemisphere Publishing, New York.
24. Leid, M., Kastner, P., and Chambon, P. (1992). Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem. Sci. 17, 427-433.
25. Leo, M. A., Iida, S., and Lieber, C. S. (1984). Retinoic acid metabolism by a system reconstituted with cytochrome P-450. Arch. Biochem. Biophys. 234, 305-312.
26. Levin, A. A., Sturzenbecker, L. J., Kazmer, S., Bosakowski, T., Huselton, C., Allenby, G., Speck, J., Kratzeisen, C., Rosenberger, M., Lovey, A., and Grippo, J. F. (1992). A new pathway for vitamin A: Understanding the pleiotropic effects of retinoids. Ann. NY Acad. Sci. 669, 70-85.
27. Lippman, S. M., Kessler, J. F., and Meyskens, F. L. (1987a). Retinoids as preventive and therapeutic anticancer agents (Part I). Cancer Treat. Rep. 71, 391-405.
28. Lippman, S. M., Kessler, J. F., and Meyskens, F. L. (1987b). Retinoids as preventive and therapeutic anticancer agents (Part II). Cancer Treat. Rep. 71, 493-515.
29. Loeliger, P., Bollag, W., and Mayer, H. (1980). Arotenoids, a new class of highly active retinoids. Eur. J. Med. Chem. 1, 9-15.
30. Maden, M., and Summerbell, D. (1986). Retinoic acid-binding protein in the chick limb bud: identification at developmental stages and binding affinities of various retinoids. J. Embryol. Exp. Morph. 97, 239-250.
31. Mangelsdorf, D. J., Ong, E. S., Dyck, J. A., and Evans, R. M. (1990). Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345, 224-229.
32. McClean, S. W., Ruddel, M. E., Gross, E. G., DeGlovanna, J. J., and Peck, G. L. (1982). Liquid-chromatographic assay for retinol (vitamin A) and retinol analogs in therapeutic trials. Clin. Chem. 28, 693-696.
33. McCormick, A. M., D'Ortona Kroll, K., and Napoli, J. L. (1983). 13-cis-Retinoic acid metabolism in vivo. The major tissue metabolites in the rat have the all-trans configuration. Biochemistry 22, 3933-3940.
34. Napoli, J. L., Posch, K. P., Fiorella, P. D., and Boerman, M. H. (1991). Physiological occurrence, biosynthesis and metabolism of retinoic acid: Evidence for roles of cellular retinol-binding protein (CRBP) and cellular retinoic acid-binding protein (CRABP) in the pathway of retinoic acid homeostasis. Biomed. Pharmacother. 45, 131-143.
35. Nervi, C., Grippo, J. F., Sherman, M. I., George, M. D., and Jetton, A. M. (1989). Identification and characterization of nuclear retinoic acid-binding activity in human myeloblastic leukemia HL-60 cells. Proc. Natl. Acad. Sci. USA 86, 5854-5858.
36. Newton, D. L., Henderson, W. R., and Sporn, M. B. (1980). Structure-activity relationships of retinoids in hamster tracheal organ culture. Can. Res. 40, 3413-3425.
37. Puck, T. T., Cieciura, S. J., and Robinson, A. (1958). Genetics of somatic mammalian cells: Long-term cultivation of euploid cells from human and animal subjects (Part III). Exp. Med. 108, 945-955.
38. Roberts, A. B., Nichols, M. D., Newton, D. L., and Sporn, M. B. (1979). In vitro metabolism of retinoic acid in hamster intestine and liver. J. Biol. Chem. 254, 6296-6302.
39. Saurai, J. H. (1984). Retinoids: New Trends in Research and Therapy. Karger, Basel.
40. Scatchard, G. (1949). The attractions of proteins for small molecules and ions. Ann. NY Acad. Sci. 51, 660-672.
41. Schiff, L. J., Okamura, W. H., Dawson, M. I., and Hobbs, P. D. (1990). In Chemistry and Biology of Synthetic Retinoids (M. I. Dawson and W. H. Okamura, Eds.), pp. 353-354. CRC Press, Boca Raton, FL.
42. Sporn, M. B., Clamon, G. H., Dunlop, N. M., Newton, D. L., Smith, J. M., and Saffiotti, U. (1975). Activity of vitamin A analogues in cell cultures of mouse epidermis and organ cultures of hamster trachea. Nature 253, 47-49.
43. Sporn, M. B., Roberts, A. B., Goodman, D. S. (Eds.) (1984). In The Retinoids, Vol. 1, pp. 240-244. Academic Press, Orlando, FL.
44. Strickland, S., Breitman, T. R., Frickel, F., Nurrenbach, A., Hadicke, E., and Sporn, M. (1983). Structure-activity relationships of a new series of retinoidal benzoic acid derivatives as measured by induction of differentiation of murine F9 teratocarcinoma cells and human HL-60 promyelocytic leukemia cells. Can. Res. 43, 5268-5272.
45. Warkany, J., and Nelson, R. C. (1940). Appearance of skeletal abnormalities in offspring of rats reared on deficient diet. Science 92, 383-384.